Go Pro

Design Therapeutics (DSGN) Stock Chart & Stock Price History

Design Therapeutics logo
$12.24 -0.33 (-2.63%)
Closing price 10/1/2026 04:00 PM Eastern
Extended Trading
$12.74 +0.50 (+4.09%)
As of 08:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Design Therapeutics Stock Price Performance

The Design Therapeutics (DSGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 103.66%, with a year-to-date return of 30.49%. In the past month, the stock has decreased 21.18%, reflecting recent market activity.

As of the latest close, Design Therapeutics traded at $12.24 with a market cap of $765.98 million and volume of 346,590 shares. Five years ago, the stock traded at $14.99, representing a 18.35% decrease over that period. At the time, it had a market cap of $833.70 million and a volume of 63,078 shares.

Receive DSGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Design Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.99%
1 Month
Performance
-21.18%
3 Month
Performance
-21.74%
Year-To-Date
Performance
+30.49%
1 Year
Performance
+103.66%
5 Year
Performance
-18.35%

DSGN Stock Chart for Friday, October, 2, 2026

Design Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
10/01/2026$12.57$12.24
-2.63%
$12.82$12.21346,590 shs$765.98 million
09/30/2026$12.62$12.57
-0.40%
$12.82$12.40589,520 shs$786.66 million
09/29/2026$12.36$12.62
+2.10%
$12.75$12.02655,798 shs$789.76 million
09/28/2026$12.12$12.36
+1.98%
$12.49$11.85433,134 shs$773.49 million
09/25/2026$12.24$12.12
-0.98%
$12.51$11.97434,470 shs$758.47 million
09/24/2026$12.36$12.24
-0.97%
$12.32$11.83459,742 shs$766.00 million
09/23/2026$13.16$12.36
-6.08%
$13.25$12.12738,274 shs$773.49 million
09/22/2026$12.55$13.16
+4.86%
$13.30$12.40506,539 shs$823.55 million
09/21/2026$12.24$12.55
+2.53%
$12.65$12.15506,417 shs$785.40 million
09/18/2026$12.81$12.24
-4.45%
$12.88$12.242.55 million shs$766.00 million
09/17/2026$12.51$12.81
+2.40%
$12.90$12.17601,078 shs$801.65 million
09/16/2026$12.23$12.51
+2.29%
$12.86$12.22985,134 shs$782.88 million
09/15/2026$13.52$12.23
-9.54%
$13.52$12.161.28 million shs$765.38 million
09/14/2026$14.63$13.52
-7.59%
$14.76$13.431.26 million shs$846.08 million
09/11/2026$14.80$14.63
-1.15%
$15.14$14.43715,231 shs$915.55 million
09/10/2026$15.02$14.80
-1.46%
$15.00$14.51652,988 shs$926.18 million
09/09/2026$15.23$15.02
-1.38%
$15.49$14.87821,136 shs$939.98 million
09/08/2026$15.14$15.23
+0.59%
$15.39$14.71775,062 shs$953.09 million
09/07/2026$15.14$15.14$15.35$14.96256,616 shs$947.46 million
09/04/2026$15.03$15.14
+0.73%
$15.35$14.96256,616 shs$947.46 million
09/03/2026$15.53$15.03
-3.22%
$15.49$14.83376,169 shs$940.58 million
09/02/2026$15.14$15.53
+2.58%
$15.75$15.171.00 million shs$971.87 million
09/01/2026$15.09$15.14
+0.33%
$15.22$14.64476,964 shs$947.46 million

This page (NASDAQ:DSGN) was last updated on 10/1/2026 by MarketBeat.com Staff.
From Our Partners